FOGHORN THERAPEUTICS INC (FHTX) Stock Analyst Earnings Estimates
NASDAQ:FHTX - Nasdaq - US3441741077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.32M 206.98% | 19.23M 1,356.82% | 34.155M 77.61% | 31.327M -8.28% | 33.926M 8.30% | 40.526M 19.45% | 42.97M 6.03% | 60.413M 40.59% | 106.3M 75.96% | 93.746M -11.81% | 194.52M 107.50% | 339M 74.28% | |
| EBITDA YoY % growth | -97.54M -45.08% | -113.84M -16.71% | -104.455M 8.24% | -96.151M 7.95% | -102.511M -6.61% | -102.393M 0.11% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -100.74M -47.00% | -117.14M -16.28% | -107.906M 7.88% | -102.252M 5.24% | -94.715M 7.37% | -90.528M 4.42% | -145.718M -60.96% | -117.665M 19.25% | -93.387M 20.63% | -149.01M -59.56% | -59.056M 60.37% | 73.408M 224.30% | |
| Operating Margin | -7,631.82% | -609.15% | -315.93% | -326.40% | -279.18% | -223.38% | -339.11% | -194.77% | -87.85% | -158.95% | -30.36% | 21.65% | |
| EPS YoY % growth | -2.70 39.94% | -2.62 2.96% | -2.34 10.69% | -1.66 28.89% | -1.31 21.36% | -1.01 22.69% | -2.05 -103.02% | -1.71 16.89% | -1.32 22.71% | -2.53 -92.14% | -1.10 56.54% | 1.30 217.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 41.46% | -0.38 35.52% | -0.38 14.93% | -0.38 -23.17% | -0.26 23.43% | -0.35 8.85% | -0.35 9.41% | -0.36 6.50% | -0.33 -27.74% |
| Revenue Q2Q % growth | 7.483M 29.71% | 5.571M 10.32% | 5.654M -17.92% | 5.741M -26.47% | 9.181M 22.69% | 16.32M 192.95% | 16.32M 188.65% | 16.32M 184.27% | 16.32M 77.76% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.182M 5.01% | -26.341M 6.57% | -26.639M -9.92% | -27.649M -15.92% | -21.579M 10.77% | -20.969M 20.39% | -21.341M 19.89% | -21.718M 21.45% | -22.098M -2.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 8.82% | -0.45 | 0.14 | 30.99% |
| Q2 2024 Q2Q % growth | -0.45 35.71% | -0.67 | 0.22 | 32.64% |
| Q1 2024 Q2Q % growth | -0.59 19.18% | -0.65 | 0.06 | 8.69% |
| Q4 2023 Q2Q % growth | -0.57 17.39% | -0.78 | 0.21 | 26.78% |
| Q3 2023 Q2Q % growth | -0.34 45.16% | -0.76 | 0.42 | 55.54% |
| Q2 2023 Q2Q % growth | -0.70 -6.06% | -0.75 | 0.05 | 6.63% |
| Q1 2023 Q2Q % growth | -0.73 -12.31% | -0.74 | 0.01 | 1.28% |
| Q4 2022 Q2Q % growth | -0.69 6.76% | -0.63 | -0.06 | -9.46% |
| Q3 2022 Q2Q % growth | -0.62 12.68% | -0.63 | 0.01 | 1.96% |
| Q2 2022 Q2Q % growth | -0.66 -4.76% | -0.60 | -0.06 | -9.21% |
| Q1 2022 Q2Q % growth | -0.65 -4.84% | -0.53 | -0.12 | -21.96% |
| Q4 2021 Q2Q % growth | -0.74 60.22% | -0.50 | -0.24 | -48.67% |
| Q3 2021 Q2Q % growth | -0.71 77.24% | -0.68 | -0.03 | -4.41% |
| Q2 2021 Q2Q % growth | -0.63 | -0.64 | 0.01 | 1.44% |
| Q1 2021 Q2Q % growth | -0.62 | -0.64 | 0.02 | 3.52% |
| Q4 2020 Q2Q % growth | -1.86 | -0.46 | -1.40 | -305.23% |
| Q3 2020 Q2Q % growth | -3.12 | -1.75 | -1.37 | -77.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 7.808M -55.33% | 6.465M | 1.343M | 20.77% |
| Q2 2024 Q2Q % growth | 6.888M 23.02% | 6.161M | 727K | 11.80% |
| Q1 2024 Q2Q % growth | 5.05M -4.88% | 7.05M | -2M | -28.37% |
| Q4 2023 Q2Q % growth | 5.769M 38.01% | 4.714M | 1.055M | 22.38% |
| Q3 2023 Q2Q % growth | 17.478M 163.62% | 4.611M | 12.867M | 279.05% |
| Q2 2023 Q2Q % growth | 5.599M 24.70% | 6.388M | -789K | -12.35% |
| Q1 2023 Q2Q % growth | 5.309M 35.43% | 5.138M | 171K | 3.33% |
| Q4 2022 Q2Q % growth | 4.18M 488.73% | 8.648M | -4.468M | -51.67% |
| Q3 2022 Q2Q % growth | 6.63M 16,475.00% | 9.384M | -2.754M | -29.35% |
| Q2 2022 Q2Q % growth | 4.49M 1,503.57% | 8.861M | -4.371M | -49.33% |
| Q1 2022 Q2Q % growth | 3.92M 1,251.72% | 8.619M | -4.699M | -54.52% |
| Q4 2021 Q2Q % growth | 710K 184.00% | 165.75K | 544.25K | 328.36% |
| Q3 2021 Q2Q % growth | 40K -77.78% | 170.003K | -130.003K | -76.47% |
| Q2 2021 Q2Q % growth | 280K | 255K | 25K | 9.80% |
| Q1 2021 Q2Q % growth | 290K | 170.003K | 119.997K | 70.58% |
| Q4 2020 Q2Q % growth | 250K | 510K | -260K | -50.98% |
| Q3 2020 Q2Q % growth | 180K | 510K | -330K | -64.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 13.46% | 13.46% | 0.71% | 9.09% |
| Revenue | 3.47% | 3.47% | -1.16% | 0.45% |